Related by context. All words. (Click for frequent words.) 66 CYT# potent vascular disrupting 65 Immune reconstitution syndrome 64 very badly Berlinschi 64 K ras mutations 64 pharmacokinetic interactions 64 Tumor shrinkage 63 Pernicious anemia 63 relapsed MM 63 Ribavirin causes 63 C1 INH deficiency 63 recurrent glioblastoma multiforme 63 EXJADE 63 GRNOPC1 contains 63 radiosensitive 63 myelofibrosis polycythemia vera 62 Hypertensive adverse reactions 62 PSMA ADC 62 Lenocta TM sodium stibogluconate 62 HER2 positive breast 62 lenalidomide dexamethasone 62 dose proportionality 62 receiving XGEVA 62 Relapsing remitting MS 62 colorectal adenocarcinoma 62 interleukin IL -# 62 Gleevec resistant 61 dyskeratosis congenita 61 Atopic dermatitis 61 hypereosinophilic syndrome 61 MAGE A3 ASCI 61 antiangiogenic therapy 61 trastuzumab Herceptin ® 60 Febrile neutropenia 60 demonstrated antitumor activity 60 Arranon 60 via intradermal injections 60 HER2 positivity 60 headache abdominal pain 60 adjuvant systemic 60 poststroke depression 60 PCNSL 60 pyrazinamide 60 surgical debulking 60 squamous cell lung cancer 60 unresectable tumors 60 decompensated liver disease 60 receiving VELCADE 60 HER2 overexpression 60 genital lesions 60 pegylated liposomal doxorubicin 60 non resectable metastatic 60 paclitaxel Taxol R 60 candidemia 60 lung cancer NSCLC 60 Leukemias 60 follicular lymphomas 59 liver metastasis 59 cisplatin resistant 59 Squamous cell 59 constipation OIC 59 Helicobacter infection 59 Venous thromboembolism 59 severe hypersensitivity reactions 59 conventional DMARDs 59 clinical trials XIFAXAN 59 refractory colorectal cancer 59 medically inoperable 59 Plaque psoriasis 59 Myelosuppression 59 allogeneic HSCT 59 relapsed SCLC 59 riociguat 59 thrombocytopenia neutropenia 59 prospectively stratified 59 cisplatin gemcitabine 59 TNF blocker therapy 59 angiogenesis inhibition 59 kidney urologic 59 VANTAS ® 59 TRAIL induced apoptosis 59 Ovarian cysts 59 mg/m2 cohort 59 Difficulty swallowing 59 LHRH agonists 59 SSc 59 Peginterferon alfa 2b 59 B7 H3 59 rates Tangka 59 selective modulator 59 d l leucovorin 59 thalidomide Thalomid 59 adrenal suppression 59 relapsed ovarian cancer 59 peritoneal carcinomatosis 59 Candida infection 59 hyperactivated 59 included exfoliative dermatitis 59 idarubicin 59 cytopenias 59 HBeAg seroconversion 59 osteosarcomas 59 Anal cancer 59 EGFR tyrosine kinase inhibitors 58 Hepatotoxicity 58 doxorubicin Adriamycin 58 refractory CLL 58 prodromal phase 58 Acute myelogenous leukemia 58 Nothing Wadden 58 castrate resistant 58 Ischaemic heart 58 Chronic pancreatitis 58 LHRH receptor positive 58 LC#m# vaccine 58 lichen planus 58 hyperalgesia 58 haematologic 58 dizziness imbalance 58 GIST tumors 58 Systemic lupus erythematosus 58 vinca alkaloid 58 BEXXAR Therapeutic Regimen 58 RhuDex R 58 Pemetrexed 58 gastric adenocarcinoma 58 adriamycin 58 Chronic lymphocytic leukemia 58 anemia thrombocytopenia 58 heavily pretreated 58 samalizumab 58 torsade de pointes 58 Seborrheic dermatitis 58 mucinous 58 Severe hypersensitivity reactions 58 primary immunodeficiency PI 58 hematological parameters 58 diaper dermatitis 58 Teriflunomide 58 histologic subtype 58 Hypotension 58 Chronic lymphocytic leukemia CLL 58 FUSILEV enhances 58 advanced carcinoid 58 Respiratory syncytial virus RSV 58 flavopiridol 58 nonbacterial prostatitis 58 Postherpetic neuralgia 58 Nausea vomiting diarrhea 58 Adjuvant therapy 58 Albuferon albinterferon alfa 2b 58 basal cell nevus syndrome 58 APTIVUS r 58 oncogenic transformation 58 upon rechallenge 58 metastatic gastric 58 doxorubicin cyclophosphamide 58 Metastatic prostate cancer 58 Bronchiectasis 58 gastrointestinal stromal tumors GISTs 58 antiandrogens 58 metastatic bladder 58 LCMV infection 58 refractory Hodgkin 58 invasive carcinoma 58 localized renal 58 Atopic eczema 58 Known hypersensitivity 58 recurrent glioblastoma 58 taxane chemotherapy administered 57 castration resistant hormone refractory 57 P falciparum 57 Acute myeloid leukemia 57 extrapyramidal symptoms EPS 57 Magnesium deficiency 57 immuno compromised individuals 57 Skin rashes 57 PR interval prolongation 57 androgen ablation therapy 57 hematopoietic cancers 57 renal carcinoma 57 intravenous bisphosphonates 57 xenograft models 57 clinicopathological features 57 Febrile seizures 57 intravenous immunoglobulin IVIg 57 immunocompetent 57 T#I [002] 57 Papillary 57 symptom flare ups 57 tumor histology 57 Decitabine 57 pancreatic adenocarcinoma 57 Chlamydia trachomatis infection 57 IFN γ 57 hormone refractory 57 hepatocellular carcinomas 57 pheochromocytoma 57 Carcinoid tumors 57 lenalidomide Revlimid R 57 Bacterial conjunctivitis 57 huN# DM1 57 relapsed ALL 57 extramedullary 57 Oral corticosteroids 57 hamartomas 57 FVIII inhibitors 57 pharmacokinetic characteristics 57 imatinib resistance 57 paclitaxel cisplatin 57 lymphomas leukemias 57 erythema nodosum 57 therapeutic regimens 57 pegylated alpha interferon 57 prostate carcinoma 57 multitargeted 57 nutlin 3a 57 commercialize deforolimus 57 novel VDA molecule 57 Sezary syndrome 57 STAT3 signaling 57 autoinflammatory diseases 57 vitamin B# folic acid 57 renal cell carcinomas 57 glial tumors 57 papillomas 57 transfusion syndrome 57 Chronic constipation 57 skeletal metastases 57 leiomyomas 57 antitumour activity 57 complement inhibitor eculizumab 57 refractory acute myeloid 57 androgen depletion 57 leukemia APL 57 Suicidal tendencies 57 erythema edema 57 Glucocorticoids 57 myeloproliferative diseases 57 Irritable bowel syndrome IBS 57 Jingle spina bifida 57 Malignant glioma 57 Identical quadruplets 57 Malignant Glioma 57 GI motility disorders 57 Bezielle 57 superficial bladder cancer 57 neurological manifestations 57 mutated K ras 57 CD#c 57 investigational monoclonal antibody 57 antiandrogen 57 Cryptococcus neoformans 57 Ceplene/IL-2 57 refractory chronic lymphocytic 57 mitoxantrone plus 57 docetaxel Taxotere ® 57 anaphylactic reactions bronchospasm 57 cytologically 57 Atypical Hemolytic Uremic Syndrome 57 BCG refractory carcinoma 57 telomerase inhibition 57 neutropenic patients 57 differentiated thyroid 57 cortical dysplasia 57 relapsed leukemia 57 Ectopic pregnancy 56 postoperative chemotherapy 56 BRAF V#E mutation 56 Interferon alpha 56 ANCA associated 56 Vincristine 56 Chronic renal failure 56 carcinoid 56 Velcade bortezomib 56 Antitumor Activity 56 systemic mastocytosis 56 gemcitabine Gemzar ® 56 Tay Sachs thalassemia 56 treating sarcoma testicular 56 superficial basal cell carcinoma 56 IFN gamma 56 leukemia AML 56 Rectal bleeding 56 erlotinib Tarceva ® 56 IDH mutations 56 cytoreduction 56 hormonally sensitive 56 Toxicities 56 radiation chemoradiation 56 undergoing peritoneal dialysis 56 dopaminergic therapy 56 radiochemotherapy 56 immunological responses 56 Gamunex C 56 hormone deprivation 56 p# activation 56 prolonged QT interval 56 primary hyperparathyroidism 56 breast carcinomas 56 Credible accredited 56 intracranial hemorrhage ICH 56 Systemic lupus 56 gastric carcinoma 56 Basal Cell 56 ovarian endometrial 56 sCD# 56 plexiform 56 serologically active systemic lupus 56 Hematologic toxicity 56 IMA# 56 CIMZIA ™ 56 Aptivus ® 56 By Lisa Eckelbecker 56 treating neuropathic pain 56 cilengitide 56 thiopurine drugs 56 systemic corticosteroid 56 Waldenstrom macroglobulinemia 56 antiretroviral naïve 56 nephrotoxicity 56 serum phosphate 56 Acute Bacterial Sinusitis ABS 56 premalignant lesions 56 8mg/kg 56 antioxidant supplementation 56 miglustat 56 pegylated interferons 56 galiximab 56 platelet dysfunction 56 CHOP chemotherapy 56 TACI Ig 56 leiomyoma 56 acetonide FA 56 membranous nephritis 56 certolizumab 56 neovascular diseases 56 symptomatic hyponatremia 56 transgene expression 56 Anaphylactic reactions 56 Gliomas 56 vitamin D inadequacy 56 maximally tolerated lipid lowering 56 Mucositis 56 candidiasis 56 essential thrombocythemia 56 CD# + [001] 56 herpetic keratitis 56 Squamous 56 EndoTAGTM 1 56 pancytopenia 56 Thyroid nodules 56 relapsing remitting MS RRMS 56 indolent follicular non 56 Yeast infections 56 TTR amyloidosis 56 By Priyanka Dayal 56 Adjuvant chemotherapy 56 completely resected 56 ZACTIMA TM ZD# 56 virologic responses 56 biliary strictures 56 amnestic 56 orchitis 56 Hurthle cell 56 invasive lobular carcinoma 56 proton MR spectroscopy 56 moderate renal impairment 56 methicillin susceptible Staphylococcus aureus 56 globulins 56 empiric treatment 56 Chronic Lyme disease 56 malignant prostate 56 hematological toxicity 56 Doxil ® 56 decitabine 56 Riluzole 56 beta lactam antibiotic 56 oral talactoferrin 56 chlamydial infection 56 VELCADE melphalan 56 pyelonephritis 56 sulfasalazine 56 imatinib Gleevec ® 56 paclitaxel Taxol ® 56 acute febrile 56 By Tennille Tracy 56 Acute pancreatitis 56 pexelizumab trials 56 Nonalcoholic fatty liver 56 vismodegib 56 Lichen planus 56 infusional 56 Human papillomavirus 56 MGd 56 mycosis fungoides 56 uterine cervix 56 tumor regressions 56 cramping abdominal pain 56 Chronic Prostatitis 56 carcinoids 56 Acne vulgaris 56 Metastatic breast cancer 55 malignant ascites 55 neutralizing antibody responses 55 dramatically Ruffo curious 55 phthalate syndrome 55 bortezomib refractory 55 bacteraemia 55 myelodysplastic myeloproliferative diseases 55 Irritable bowel syndrome 55 chemotherapy cisplatin 55 radiolabeled TM# 55 visceral metastases 55 recombinant interferon 55 IgG isotype 55 Basal cell 55 Intussusception 55 operable breast cancer 55 malignant ovarian 55 papillary renal cell carcinoma 55 insulin secreting beta 55 trabectedin 55 pouchitis 55 metastatic renal cell 55 methotrexate therapy 55 biliary tract cancer 55 dose escalation phase 55 malignant pleural mesothelioma 55 SCIg 55 anticholinergic agents 55 transaminase elevations 55 bladder ovarian 55 pCR 55 Soft Tissue Sarcoma 55 NOMID 55 colorectal liver metastases 55 dermatofibrosarcoma protuberans 55 localized prostate 55 Kinoid 55 immune modulating 55 rheumatological 55 TroVax ® 55 P. falciparum malaria 55 alpha interferons 55 serum leptin 55 Abscesses 55 Trastuzumab 55 Viral gastroenteritis 55 AML MDS 55 proliferative disorders 55 basal cell carcinoma BCC 55 humoral immune responses 55 cystic fibrosis chronic pancreatitis 55 Endometrial cancer 55 scombroid poisoning 55 elevated ALT 55 E#F# 55 gemifloxacin 55 pituitary adenomas 55 non beneficial neutrophil 55 basiliximab 55 lesional 55 cisplatin chemotherapy 55 chronic hepatitis cirrhosis 55 Aviptadil 55 VaD 55 androgen excess 55 malignant pancreatic 55 mucocutaneous reactions 55 imatinib resistant 55 hyperprolactinemia 55 hematological malignancy 55 deCODE BreastCancer 55 allodynia 55 castration resistant 55 Colon polyps 55 activin 55 FOSRENOL ® 55 IAP inhibitor 55 CP CPPS 55 metastatic uveal melanoma 55 MALT lymphoma 55 MDS AML 55 LHRH analogues 55 gastric carcinomas 55 Multivariate analyzes 55 concomitant antibiotics 55 Genital herpes 55 hormone receptor negative 55 MMP inhibitors 55 immunosuppressive therapies 55 Cutaneous anthrax 55 Platinol ® cisplatin 55 autoantibody positive 55 viral kinetics 55 Alternative splicing 55 malignant pheochromocytoma 55 pediatric acute lymphoblastic 55 anti angiogenic agents 55 NSCLC tumors 55 pelvic malignancies 55 ispinesib administered 55 Immune responses 55 By Shaun Sutner 55 adalimumab etanercept 55 grade cervical intraepithelial 55 Mild jaundice 55 nonvaccine 55 BRAF mutations 55 systemic autoimmune 55 Heavy menstrual bleeding 55 Paroxysmal Nocturnal Hemoglobinuria PNH 55 EGF receptor 55 systemic immunosuppressive 55 Oral mucositis 55 biliary obstruction 55 Helicobacter pylori H. pylori 55 endometrial hyperplasia 55 thrombocytosis 55 nonmetastatic 55 SNT MC# 55 ADPKD 55 intradermal injection 55 surgically resectable 55 Pleural mesothelioma 55 esthesioneuroblastoma rare form 55 rituximab refractory 55 Renal impairment 55 Prostate enlargement 55 GVAX Pancreas Vaccine 55 fever headaches nausea 55 anti angiogenic therapy 55 multi factorial disease 55 becoming growingly numb 55 oseltamivir resistance 55 metastatic malignant 55 Uveal melanoma 55 Viral load 55 recurrent NSCLC 55 CIPN 55 EGFR mutation positive 55 Eliezer Zomer Ph.D. 55 virologic suppression 55 osteolytic bone disease 55 interferon IFN 55 genital herpes infections 55 delayed CINV 55 metastatic kidney 55 essential thrombocythemia ET 55 leukemias lymphomas 55 accompanying electrolyte abnormalities 55 Nasal spray flu 55 psoriatic arthritis PsA 55 Pancreatic neuroendocrine tumors 55 chromosomal rearrangement 55 comorbid disorders 55 Subgroup analyzes 55 pamidronate 55 ribavirin RBV 55 Cerebral malaria 55 elevated LDH 55 nadolol 55 paroxysmal AF 55 bacteria Mycobacterium tuberculosis 55 stem cell transplantations 55 refractory myeloma 55 familial ALS 55 epithelial tumors 55 CYP #D# 55 Paraplatin ® carboplatin 55 humanised monoclonal antibody 55 BRAF V# mutation 55 alkylating agent 55 aphthous ulcers 55 anti androgen 55 angioneurotic edema 55 called nephrogenic fibrosing 55 Vidaza ® 55 cyclophosphamide methotrexate 55 concomitantly administered 55 Diabetic macular edema 55 Wilms tumors 55 Crizotinib 55 adult chronic ITP 55 Radical prostatectomy 55 Chronic sinusitis 55 node metastases 55 chronic myeloid 55 intravenous cyclophosphamide 55 FSH receptor 55 boys Khoran Brown 55 PCOD 55 Sapacitabine 55 prostate cancer CaP 55 pegfilgrastim 55 APTIVUS ritonavir 55 Menopausal symptoms 55 ACTEMRA TM 55 potent antiretroviral therapy 55 immune thrombocytopenic purpura 55 rituximab Rituxan 55 EGFR HER2 55 TEMODAL 55 underwent surgical resection 55 GnRH agonists 55 LRP5 55 SUSTENNA TM 55 seminomas 55 virally induced 54 lymph node enlargement 54 nonsquamous 54 osteoblastic 54 stage IIIb 54 hemorrhagic cerebrovascular events 54 ER CHOP 54 Glioblastoma Multiforme GBM 54 benign biliary strictures 54 ADVEXIN therapy 54 Epigenetic changes 54 Human papillomavirus HPV 54 Meningiomas usually occur 54 Pulmonary arterial hypertension 54 Basal cell carcinoma 54 Seliciclib 54 CTAP# 54 Hashimoto thyroiditis 54 alefacept 54 coinfected patients 54 folinic acid 54 intra abdominal infections 54 Ph + acute lymphoblastic 54 colorectal carcinoma 54 dasatinib Sprycel 54 herpes zoster virus 54 interferon ribavirin 54 prognostically 54 follicular lymphoma FL 54 adjuvant cisplatin 54 transplantation HCT 54 Anthracycline 54 vulvar intraepithelial neoplasia 54 Pelvic inflammatory 54 cediranib 54 Plantar warts 54 Polycythemia vera 54 Prenatal Alcohol 54 Intravenous immunoglobulin 54 GONZALES Monica 54 bacterial vaginosis BV 54 GRN# 54 pharmacologic intervention 54 5 fluorouracil leucovorin 54 microtubule targeting 54 nonmelanoma skin cancers 54 MGUS 54 deCODE ProstateCancer TM 54 corticosteroid dexamethasone 54 pancreatic colon 54 posterior uveitis 54 paraganglioma 54 cervical lymph nodes 54 malignant lymphomas 54 Relapsed Refractory 54 hypertrophic scars 54 pigment alters 54 commercializes propriety products 54 myelogenous leukemia 54 Epstein Barr virus EBV 54 Premature ejaculation 54 Dental caries 54 Temporal lobe epilepsy 54 pancreatic prostate 54 Polycystic ovary syndrome 54 Genital HPV 54 chronic eosinophilic leukemia 54 malabsorptive 54 vWD 54 necrotizing pneumonia 54 Myelodysplastic Syndrome 54 tumoral 54 BY RYAN BENTLEY 54 abdominal ultrasounds 54 relapsed Acute Myeloid 54 refractory metastatic 54 T1c 54 weekly intravenous infusions 54 familial aggregation 54 sarcomatoid 54 Hydroxyurea 54 hoFH 54 interferon alfa 2b 54 clinicopathological 54 Severe infusion 54 cholangiocarcinoma 54 spontaneous remission 54 Akt activation 54 Clusterin 54 Fluid retention 54 monoclonal antibodies aptamers 54 Norovirus infection 54 concurrent chemoradiation 54 cidofovir 54 constipation predominant irritable bowel 54 sacral neuromodulation 54 acute gout flares 54 Chronic myeloid leukemia 54 dysplastic lesions caused 54 IgG4 54 acute lymphoblastic 54 perioperatively 54 arterial thickening 54 debilitating complication 54 cellular prion protein 54 phenothiazines 54 Hypersensitivity reactions 54 metastatic colorectal 54 Metastatic colorectal cancer 54 immunosuppressives 54 epiglottitis 54 erlotinib Tarceva 54 factor TNF receptor 54 baseline LDH 54 Cutaneous T 54 pulmonary metastasis 54 dermatologic reactions 54 FDG PET imaging 54 pharynx larynx 54 ACR# responses 54 cervical carcinoma 54 intra arterial chemotherapy 54 dirucotide MBP# 54 leukemia ALL 54 Anthracyclines 54 oseltamivir resistant 54 FOLFOX chemotherapy 54 Dose limiting toxicities 54 nonfatal diarrhea 54 Renal Impairment 54 undergoing hematopoietic stem 54 ano genital warts 54 DOXIL 54 gene rearrangements 54 INCB# [003] 54 tumors GIST 54 Ankylosing spondylitis 54 Hepatic encephalopathy 54 ErbB receptors 54 panobinostat 54 gastrointestinal stromal tumors GIST 54 Estrogen Receptor 54 pAkt 54 hepatic metastases 54 Baseline characteristics 54 multisystem disease 54 null responder 54 Uncontrolled hypertension 54 underlying pathophysiology 54 hypercalcemia 54 mesotheliomas 54 papillary thyroid carcinoma 54 antiphospholipid antibodies 54 maximal doses 54 leukemia CLL 54 cefotaxime 54 refractory acute promyelocytic 54 Cardiotoxicity 54 mitogen activated protein kinases 54 unfavorable cytogenetics 54 chronic granulomatous disease 54 vasogenic edema 54 abnormal clotting 54 HuLuc# 54 imipenem 54 androgen ablation 54 Ketoacidosis 54 non metastatic osteosarcoma 54 Letairis ambrisentan 54 allogeneic hematopoietic stem cell 54 postoperative pathology 54 refractory AML 54 aT cell 54 lung pancreatic 54 malignant pleural effusion 54 sporadic Creutzfeldt Jakob 54 vascular endothelial dysfunction 54 By Dennis Rockstroh 54 non hematological toxicities 54 RAPTIVA 54 oral herpes 54 Cardiopulmonary bypass 54 ara C 54 androgen suppression 54 ovarian germ 54 percutaneous biopsy 54 recurrent GBM 54 ductal carcinomas 54 DAS# remission 54 Raptiva r 54 epithelioid 54 Ebola SNALP 54 tryptase 54 Symptom onset 54 haematopoietic 54 bacterial prostatitis 54 inflammatory bowel syndrome 54 latent tuberculosis TB 54 inverse agonist 54 thoracoscopic lobectomy 54 hyperplastic 54 antibody cytokine 54 nonmelanoma 54 Surgical excision 54 astrocytomas 54 Bacterial vaginosis 54 imexon 54 TGF beta signaling 54 EGFRIs 54 Introgen ADVEXIN 54 Myelodysplastic syndromes MDS 54 LUCK Happy Birthday 54 spinal metastases 54 every ERBITUX infusion 54 MDS MPD 54 Myelodysplasia 54 Vertebral fractures 54 thymectomy 54 Hepatocellular Carcinoma HCC 54 Margaret Honein 54 beta carotene supplementation 54 By CANDIA DAMES 54 Cimzia TM 54 Lymphoid 54 rheumatic disorders 54 gastrointestinal adverse reactions 54 antimetabolite 54 By STEPHEN WILLIS 54 chemo immunotherapy 54 monocytic 54 methylation markers 54 By Laurie Kulikowski 53 advanced hepatocellular carcinoma 53 seminoma 53 dose proportional pharmacokinetics 53 relapsed AML 53 temporomandibular joints 53 thrombotic thrombocytopenic purpura TTP 53 canakinumab 53 Glioblastoma Multiforme 53 standard chemotherapy regimen 53 anterior uveitis 53 differently Widmer Schlump 53 intracerebral 53 premalignant 53 basal cell cancers 53 hypersensitivity allergic reactions 53 taxane refractory 53 Meningiomas 53 esophagogastric 53 Traficet EN 53 keloid formation 53 Nilotinib 53 hyperammonemia 53 clinically insignificant 53 Peptic ulcers 53 AChE inhibitors 53 anemia neutropenia 53 pre malignant lesions 53 preemptive analgesia 53 dysmenorrhoea 53 Videotaped depositions 53 ALT flares 53 intravascular hemolysis 53 Genetic susceptibility 53 Cell Lymphoma CTCL 53 NIELSEN Dane 53 oligodendrogliomas 53 dentinal hypersensitivity 53 epoprostenol 53 GRASPA ® 53 atypical Hemolytic Uremic Syndrome 53 allogeneic stem cell 53 antitumor effects 53 Th2 cytokines 53 Neuropathic pain 53 taxotere 53 neurofibroma 53 receiving VICTRELIS 53 Adenoviruses usually cause 53 affective psychosis 53 1 diabetes T1D 53 Sacktor 53 subependymal giant cell 53 CD8 T cell 53 poliovirus vaccine 53 ovarian suppression 53 Akt inhibitor 53 Chronic HCV 53 irregular menstrual bleeding 53 Thrombotic events 53 benign prostatic hypertrophy 53 Peritoneal mesothelioma 53 EBV infection 53 dosage regimens 53 bortezomib Velcade 53 muscular dystrophy cystic fibrosis 53 psoriasis Crohn disease 53 spontaneously regress 53 monogenic 53 hypercoagulable 53 profuse diarrhea 53 hypometabolism 53 adjuvant tamoxifen 53 infantile colic 53 Peripheral edema 53 adrenocorticotropic hormone 53 pathologic diagnosis 53 antiphospholipid syndrome 53 Retrograde ejaculation 53 Valproic acid 53 myoclonus 53 Vidofludimus 53 benign prostatic hypertrophy BPH 53 invasive lobular 53 Torsades de Pointes 53 Telintra 53 nonmyeloablative 53 unknown etiology 53 adjuvant radiotherapy 53 bony metastases 53 vinorelbine 53 inhaled bronchodilators 53 haematological malignancies 53 bullous 53 recurrent ovarian 53 AGILECT R 53 ELISPOT assay 53 Infielder Edwin Maysonet 53 PKC# 53 diabetic kidney 53 BY JIM LAMBERT 53 BPH benign prostatic 53 Warfarin Coumadin 53 euthymic 53 cytotoxic therapy 53 Lumbar spinal stenosis 53 red scaly inflamed 53 Symptom severity 53 Alopecia areata 53 oral FTY# 53 Fetal heartbeats 53 intradermal injections 53 desmoplastic 53 lupus multiple sclerosis 53 recurrent metastatic 53 p#HER# positive 53 included delirium hallucinations 53 Spike Jonze cinematic 53 benign neoplasms 53 familial pancreatic cancer 53 Urinary infections 53 atypical hemolytic uremic syndrome 53 GISTs 53 non resectable liver 53 PEGPH# 53 Bronchiolitis 53 commonly mutated genes 53 dryness irritation 53 Interstitial cystitis 53 LHRH agonist 53 achieved CCyR 53 seborrhea 53 potentiation 53 DIRECTORS OF CAPITAL CORP. 53 metastatic RCC 53 spontaneous regression 53 HbF 53 stage IIIb IV 53 myeloablative 53 Plaquenil 53 decompensated cirrhosis 53 oncologic outcomes 53 neuritic 53 Follicular lymphoma 53 VICTOR E3 53 CD# mAb 53 By SALLY SPAULDING 53 Severe Primary IGFD 53 granulomatous 53 GRNOPC1 cells 53 Actor Sonny Shroyer 53 #q# deletion syndrome 53 de novo mutations 53 bacteria Neisseria meningitidis 53 ChR2 53 histopathologic examination 53 malignant neoplasms 53 NMDA antagonist 53 Pebble Beach Calf 53 Diaper rash